Interventions May Cut Heart Dose From Radiation Therapy for NSCLC
FRIDAY, April 15, 2022 (HealthDay News) — For patients receiving radiation therapy for locally advanced non-small cell lung cancer (NSCLC), education and implementation of a standardized cardiac dose quality measure is associated with a reduction in mean heart dose (MHD), according to a study recently published in Practical Radiation Oncology.
Noting that there is significant...
Learn MorePassive Smoking Linked to Increased Risk of Rheumatoid Arthritis
FRIDAY, April 15, 2022 (HealthDay News) — Passive smoking during childhood and/or adulthood is associated with increased risk of rheumatoid arthritis (RA), according to a study recently published in RMD Open.Yann Nguyen, M.D., M.P.H., from the Univer…
Learn MoreBariatric Surgery Before TKA Cuts Complications in Obese Patients
FRIDAY, April 15, 2022 (HealthDay News) — People with severe obesity and knee osteoarthritis are advised to attempt weight loss before total knee arthroplasty (TKA) as it could reduce complications of joint surgery, according to a study published onl…
Learn MoreRate of Retinal Vein Occlusions Up After COVID-19 Infection
FRIDAY, April 15, 2022 (HealthDay News) — The risk for retinal vein occlusion (RVO) may be increased in the six months following COVID-19 infection, according to a study published online April 14 in JAMA Ophthalmology.Bobeck S. Modjtahedi, M.D., from…
Learn MoreNearly Half of Young Adults Report Mental Health Symptoms
FRIDAY, April 15, 2022 (HealthDay News) — Young adults report unmet need for mental health care, according to a study published online April 11 in the Journal of Adolescent Health.Sally H. Adams, Ph.D., from the University of California in San Franci…
Learn MoreRecently Discharged Patients Pose Risk for Spreading C. Difficile Infection
FRIDAY, April 15, 2022 (HealthDay News) — Asymptomatic patients recently discharged from a hospital may be a source of household transmission of Clostridioides difficile infection (CDI), according to a study published in the May issue of Emerging Inf…
Learn MoreAxicabtagene Ciloleucel Approved for Second-Line Treatment of LBCL
FRIDAY, April 15, 2022 (HealthDay News) — Axicabtagene ciloleucel (axi-cel; Yescarta) was approved for treatment of large B-cell lymphoma (LBCL) that is refractory to first-line chemoimmunotherapy or relapses within a year of first-line chemotherapy,…
Learn MoreWho Are the New ‘Patient Influencers’ on Social Media?
FRIDAY, April 15, 2022 (HealthDay News) — Disability activist Gem Hubbard regularly shares her insights about life in a wheelchair with more than 75,000 Instagram followers, under the handle @wheelsnoheels_, and her YouTube videos boast more than 3.7…
Learn MoreFDA Approves First Breath Test for COVID
FRIDAY, April 15, 2022 (HealthDay News) — People who suspect they may have COVID-19 could soon find out with a simple breath test that delivers results in three minutes.On Thursday, the U.S. Food and Drug Administration granted an emergency use autho…
Learn MoreNew Law Allows FDA to Police E-Cigs Made With Synthetic Nicotine
FRIDAY, April 15, 2022 (HealthDay News) — A new law will ensure that vaping companies making electronic cigarettes using synthetic nicotine, in fruit flavors that appeal to teenagers, can be regulated by the U.S. Food and Drug Administration. When th…
Learn More